glp 1 agonist trials Another milestone in the evolution of GLP-1-based diabetes therapies In the original clinical trials
Description
Obstructive sleep apnoea syndrome
Overall, 1,443 (57.1 percent) of the 2,529 live-birth pregnancies received at least one GLP-1 RA dispensation after LMP, and 1,499 (829 with continued dispensing) were linked to an infant
Endnotes Adults who say a doctor or health care provider told them they are overweight or obese in the past five years include those who may also have diabetes or heart disease
Cell Rep 17: 2845-2856, 2016
Dulaglutide utilises a large recombinant fusion protein with Fc fragment for prolonged action, achieving a 5-day half-life with once-weekly dosing [29]
Gromada J, Holst JJ, and Rorsman P
